" class="no-js "lang="en-US"> Alessandra Dorigo - Medtech Alert
Thursday, March 28, 2024
Alessandra Dorigo

Alessandra Dorigo

About Alessandra Dorigo

Related Story

MHRA Grants Marketing Authorisation for Novartis’ Radioligand Therapy Pluvicto®▼ (Lutetium (¹⁷⁷lu) Vipivotide Tetraxetan) in Advanced Prostate Cancer in Great Britain

August 15 2022

Advanced Accelerator Applications (AAA), a Novartis company,  today announced that the Medicines & Healthcare products […]

Novartis Awarded Promising Innovative Medicine Designation for Targeted Radioligand Theragnostics in Prostate Cancer

October 20 2021

Novartis today announced that the Medicines and Healthcare Products Regulatory Agency (MHRA) has granted Promising […]